Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does REGADENOSON Cause Electrocardiogram st segment depression? 20 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Electrocardiogram st segment depression have been filed in association with REGADENOSON (Regadenoson). This represents 0.7% of all adverse event reports for REGADENOSON.

20
Reports of Electrocardiogram st segment depression with REGADENOSON
0.7%
of all REGADENOSON reports
1
Deaths
3
Hospitalizations

How Dangerous Is Electrocardiogram st segment depression From REGADENOSON?

Of the 20 reports, 1 (5.0%) resulted in death, 3 (15.0%) required hospitalization, and 3 (15.0%) were considered life-threatening.

Is Electrocardiogram st segment depression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for REGADENOSON. However, 20 reports have been filed with the FAERS database.

What Other Side Effects Does REGADENOSON Cause?

Nausea (311) Dyspnoea (271) Seizure (247) Vomiting (233) Injection site extravasation (226) Hypotension (200) Headache (190) Cardiac arrest (183) Dizziness (160) Blood pressure decreased (143)

What Other Drugs Cause Electrocardiogram st segment depression?

DIGOXIN (54) EPINEPHRINE (53) QUETIAPINE (50) LAMOTRIGINE (44) AMLODIPINE (37) ASPIRIN (36) CAPECITABINE (29) METHYLPREDNISOLONE (29) TACROLIMUS (29) FLUOROURACIL (27)

Which REGADENOSON Alternatives Have Lower Electrocardiogram st segment depression Risk?

REGADENOSON vs REGORAFENIB REGADENOSON vs REGORAFENIB\REGORAFENIB REGADENOSON vs RELATLIMAB REGADENOSON vs RELPAX REGADENOSON vs RELUGOLIX

Related Pages

REGADENOSON Full Profile All Electrocardiogram st segment depression Reports All Drugs Causing Electrocardiogram st segment depression REGADENOSON Demographics